ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 90

Insufficient Evidence For An Increase In Prevalence and Incidence Of Gout: A Systematic Review and Meta-Regression Analysis

José M.A. Wijnands1, Wolfgang Viechtbauer2, Kristof Thevissen3, Ilja C.W. Arts4, Pieter C. Dagnelie4, Coen D.A. Stehouwer5, Sjef van der Linden3 and Annelies Boonen3, 1Department of Internal Medicine, Division of Rheumatology, Maastricht University, Maastricht, Netherlands, 2Department of Psychiatry and Psychology, Maastricht University, Maastricht, Netherlands, 3Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 4Department of Epidemiology, Maastricht University, Maastricht, Netherlands, 5Department of Internal Medicine, Maastricht University Medical Center, Maastricht, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Gout and meta-analysis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Estimates on the prevalence and incidence of gout in the general population vary widely and an increase is commonly reported. However, studies on the occurrence of gout have not been reviewed and appraised systematically. The aims of this study were: 1) to estimate the pooled prevalence and the incidence of gout in the general population; 2) to explore which factors contribute to the variation in estimated prevalence and incidence.

Methods: Pubmed, Embase and Web of Science were systematically searched for primary studies on the prevalence and incidence of gout in the general population. Two reviewers independently extracted data on prevalence and incidence as well as sources of clinical heterogeneity, methodological heterogeneity, and variation in outcome reporting. Prevalence rates were pooled using a random-effects model and were adjusted for a series of clinical and methodological study characteristics in a meta-regression analysis using the mixed-effects model.

Results: Of 1466 articles screened, 77 articles were included, of which 71 reported the prevalence and 12 the incidence of gout. The pooled prevalence based on a random effects model was 0.8% (95% CI 0.6; 1.0) with a high level of heterogeneity (I² =99.9%). Results from a mixed-effects meta-regression model indicated that gender (p<0.001), continent (p<0.001), consistency in data collection (p=0.003), and case definition (p=0.001) were significantly associated with gout prevalence and jointly accounted for 77.2% of the heterogeneity. Start of data collection was not associated with the prevalence. The incidence in the total population ranged from 0.06 to 2.68 per 1000 person-years and an increase in incidence was only seen in two studies.

Conclusion: The large variation in the prevalence data on gout in the general population is explained not only by well-known factors such as gender and continent on which the study was performed, but also by the case definition of gout. There was insufficient evidence for an increase in prevalence or incidence of gout in recent years.


Disclosure:

J. M. A. Wijnands,
None;

W. Viechtbauer,
None;

K. Thevissen,
None;

I. C. W. Arts,
None;

P. C. Dagnelie,
None;

C. D. A. Stehouwer,
None;

S. van der Linden,
None;

A. Boonen,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/insufficient-evidence-for-an-increase-in-prevalence-and-incidence-of-gout-a-systematic-review-and-meta-regression-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology